Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Amplify Therapeutics ApS
APS
Active
Advertising protection
CVR 43803999
Ole Maaløes Vej 3, 2200
København N
Manufacture of pharmaceutical preparations
·
NACE 2120
Est. 2023 · 3 years old
1 employees
Monitor
Share
Denmark
/
Companies
/
Manufacture of pharmaceutical preparations
/
Amplify Therapeutics ApS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (1)
TK
Thomas Kirkegaard Jensen
Management
Management
2023
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
AV
Anders Vadsholt
Board of Directors
Board of Directors
2023
AM
Anders Mørkeberg Hinsby
Chairman
Chairman
2023
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Dare to Dream ApS
Company
33.33–49.99%
33.33–49.99%
2023
WoB Holding ApS
Company
25–33.32%
25–33.32%
2023
Alpha Healthcare Investments ApS
Company
25–33.32%
25–33.32%
2023
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Amplify Therapeutics ApS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network
